America is racing to build the AI future, but Ford’s Jim Farley is warning that the country may run out of people to pour the concrete, pull the cable, and keep the servers humming long before it runs out of capital. At…
Atlanta’s latest export is no longer just peaches and hip‑hop—it is a growing pipeline of biotech and medtech startups, with GeoVax Labs (NASDAQ: GOVX) increasingly playing the role of headliner rather than opening act. In just over a year, Science Square’s Portal…
U.S. stocks drifted lower in this week, as investors digested early fourth‑quarter earnings, stubbornly mixed inflation data, and a Treasury market that seems determined to remind everyone that “higher for longer” is still a thing, even if no one wants to RSVP.…
ImmunityBio’s (NASDAQ: IBRX) latest bladder cancer update reads like the moment a niche indie film suddenly lands a studio franchise deal: the BCG‑unresponsive chapter is out, and now the company is quietly casting for the much bigger, first‑line role.
From Last Resort To First…
Eupraxia’s (NASDAQ: EPRX) once‑yearly shot at taming eosinophilic esophagitis (EoE) reads less like a niche biotech story and more like the early chapters of a franchise, with Wall Street now casting it as a potential leading role rather than a cameo. For…
Anthropic’s decision to tap Microsoft veteran Irina Ghose as its Managing Director for India reads less like a routine executive shuffle and more like a signal flare from the frontier of AI competition—Bengaluru is about to get a new large‑language landlord.
A…
Wall Street ended Wednesday with big tech nursing a hangover, small caps stealing the limelight, and investors once again discovering that the yield curve has a better sense of drama than most streaming services.
Indexes: Big Tech Blinks, Small Caps Smirk
The Nasdaq…
U.S. stocks slipped modestly on Tuesday as Wall Street digested a cooler core inflation print, a heavy dose of bank earnings, and fresh tariff salvos from Washington, leaving the major indexes just a step back from record territory rather than in full…
Wall Street kicked off the week in an ebullient mood Monday, as major U.S. equity benchmarks climbed to fresh heights while gold and silver behaved like they had just discovered caffeine
Indexes: Bulls in Full Voice
The S&P 500 added roughly 0.2%–0.3%, extending last…
The J.P. Morgan Healthcare Conference (JPM2026) is returning to San Francisco this week (Jan. 12-15, 2026) with all the familiar hallmarks: packed lobbies, overbooked coffee meetings, and the annual reminder that in healthcare, January belongs less to New Year’s resolutions and…